Together, counteraction of the IL-6-mediated pro- and anti-inflammatory effects along with the SOCS3-dependent regulation of IL-6 activity may account for the largely unaffected outcome of experimental TB in global IL-6-/- mice. This evidence concerns the gene IL6 and tuberculosis.